Related Experiment Video
Updated: Aug 29, 2025

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
Published on: March 30, 2022
CD4+ T-lymphocytes exhibit biphasic kinetics post-myocardial infarction
Vinay Kumar1,2, Sumanth D Prabhu3, Shyam S Bansal1,2,4
1Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
CD4+ T-cells play a dual role in heart conditions. Initially aiding healing after myocardial infarction (MI), they later worsen heart failure (HF) by promoting cardiac remodeling. Targeting these cells during HF could be a new treatment.
Area of Science:
- Immunology
- Cardiovascular Biology
- Pathophysiology
Background:
- CD4+ T-cells are crucial for wound healing post-myocardial infarction (MI).
- However, their role in chronic ischemic heart failure (HF) and left-ventricular (LV) remodeling is complex and not fully understood.
- Distinct T-cell activation patterns may occur during acute MI versus chronic HF.
Purpose of the Study:
- To investigate the temporal dynamics and phenotypic characteristics of cardiac CD4+ T-cells during MI and HF.
- To determine the specific role of CD4+ T-cells in promoting LV remodeling and dysfunction during chronic ischemic heart failure.
- To explore the therapeutic potential of targeting CD4+ T-cells in HF.
Main Methods:
- Flow cytometry was used to analyze cardiac CD4+ T-cell populations at different time points post-MI and during HF.
- CD4-iDTR mice were generated to enable conditional depletion of CD4+ T-cells using diphtheria toxin (DT).
- Echocardiography was performed to assess left-ventricular remodeling (volumes, ejection fraction) in control and T-cell depleted mice.
Main Results:
- Cardiac CD4+ T-cells exhibited biphasic transmigration patterns: a rapid early response post-MI and a second, sustained activation phase during HF.
- During HF, CD4+ T-cell levels were significantly elevated (approximately 20-fold) compared to sham-operated controls, affecting multiple T-cell subsets.
- Depletion of CD4+ T-cells during chronic HF significantly attenuated LV remodeling (reduced end-diastolic and end-systolic volumes) and preserved ejection fraction.
Conclusions:
- The CD4+ T-cell response during chronic heart failure differs from that during acute myocardial infarction and actively drives pathological left-ventricular remodeling.
- Sustained CD4+ T-cell activation in HF promotes progressive cardiac dysfunction.
- Temporal immunomodulation of CD4+ T-cells represents a promising therapeutic strategy for treating ischemic heart failure.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

